|
Volumn 376, Issue 7, 2017, Pages 605-607
|
Addressing the fentanyl threat to public health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
COUNTERFEIT DRUG;
FENTANYL;
HYDROCODONE BITARTRATE PLUS PARACETAMOL;
MIDOMAFETAMINE;
NALOXONE;
OXYCODONE;
NARCOTIC ANALGESIC AGENT;
NARCOTIC ANTAGONIST;
STREET DRUG;
AWARENESS;
CANADA;
CHEMICAL ANALYSIS;
DRUG ABUSE;
DRUG FORMULATION;
DRUG OVERDOSE;
DRUG SAFETY;
DRUG TRAFFIC;
DRUG USE;
EUROPE;
GOVERNMENT;
HEALTH CARE DELIVERY;
HEALTH CARE POLICY;
HEROIN DEPENDENCE;
HUMAN;
MORTALITY;
OPIATE ADDICTION;
PUBLIC HEALTH;
REVIEW;
UNITED STATES;
CHEMISTRY;
DRUG CONTROL;
OPIOID-RELATED DISORDERS;
ANALGESICS, OPIOID;
DRUG AND NARCOTIC CONTROL;
DRUG OVERDOSE;
FENTANYL;
HUMANS;
NALOXONE;
NARCOTIC ANTAGONISTS;
OPIOID-RELATED DISORDERS;
PUBLIC HEALTH;
STREET DRUGS;
UNITED STATES;
|
EID: 85013499524
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1615145 Document Type: Review |
Times cited : (175)
|
References (5)
|